Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System
Ximu Sun, Zhuo Ma, Qixiang Guo, Zhixia Zhao, Lihong Liu
Topics & Concepts
Adverse Event Reporting SystemPharmacovigilanceFood and drug administrationAdverse effectIbrutinibMedicineDrugPharmacologyAdverse drug eventInternal medicineLeukemiaChronic lymphocytic leukemiaChronic Lymphocytic Leukemia ResearchCutaneous lymphoproliferative disorders researchAutoimmune Bullous Skin Diseases